Week 2 prediction using Seq2Seq model. by Yeongha Kim (12174924)

“…However, the problem with these models is that their prediction accuracy is considerably reduced when the duration of the COVID-19 outbreak is short. In this paper, we propose a new prediction method combining Word2Vec and the existing long short-term memory and Seq2Seq + Attention model. …”

RV hypertrophy is decreased with recombinant human (rhACE2) administration. by Jennifer A. Johnson (349929)

Phosphorylation of PFK2 is decreased in cardiomyocytes cultured in the absence of insulin and with diabetes. by Craig A. Eyster (9262632)

“…(B) Quantitation of mean fluorescence intensity (MFI) for pPFK2 are presented as whisker plots that encompass data from at least 18 cells, as detailed in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0231806#pone.0231806.g001" target="_blank">Fig 1</a> (n = 3 biological replicates, and at least 6 cells per experiment). (*) IBMX or Isoproterenol treatment causes a significant increase (<i>p</i> < .001) compared to untreated WT cells; (†) Each WT (-ins) condition is significantly decreased (<i>p</i> < .001) compared to WT (+ins); (‡) all Akita conditions are significantly decreased (<i>p</i> < .001) compared to comparable WT conditions. …”

SDG decreases iron-induced inflammatory cytokine gene expression in H9c2 cells. by Stephanie Puukila (568109)

SDG decreases iron-induced caspase 3/7 activity in H9c2 cells. by Stephanie Puukila (568109)

Datasheet1_Acquired von Willebrand syndrome (AVWS) type 2, characterized by decreased high molecular weight multimers, is common in children with severe pulmonary hypertension (PH)... by Ivonne Wieland (14112981)

“…The two remaining patients had suspected AVWS type 2 because of a VWF:Ac/VWF:Ag ratio of <0.7. …”

Old rats exhibited a decrease in spontaneous daily food intake. by Aude Lafoux (643487)

H + D₂ Reaction Dynamics in the Limit of Low Product Recoil Energy by J. Aldegunde (1373448)

“…Both experiment and theory recently showed that the H + D₂(<i>v</i> = 0, <i>j</i> = 0) → HD­(<i>v</i>′ = 4, <i>j</i>′) + D reactions at a collision energy of 1.97 eV display a seemingly anomalous HD product angular distribution that moves in the backward direction as the value of <i>j</i>′ increases and the corresponding energy available for product recoil decreases. …”

Subset of selected genes showing a ≥2-fold change decrease of expression in the <i>furA</i>-turning off strain AGcoaRFurA. by Andrés González (767802)

“…<p>Subset of selected genes showing a ≥2-fold change decrease of expression in the <i>furA</i>-turning off strain AGcoaRFurA.…”

EMBS-treated cells undergo apoptosis correlated with decreased cell viability, metabolic activity and mitochondrial membrane potential. by Michelle Helen Visagie (3927308)

Probability of release is decreased by hydrophobic mutations. by Matthew R. Bowers (8423115)

Carbon intensity data for YRD region Unit:kg/m². by Jingru Zhou (766195)

“…Upon comparing carbon storage levels predicted for 2030 under the five scenarios with those in 2020, carbon stocks decrease in the initial four scenarios and then increase in the fifth scenario. …”

A low dose of BTZ decreases proteasome activity with no effect on cell viability. by A. L. Furfaro (2587792)

Planning performance decreases with decreasing oscillation frequency and is worst for a solitary wave. by Azadeh Khajeh-Alijani (767689)

Fig6B_modifiedSplitter_adjustTidalVolume_Patients_C_C_decrease: Variables for pair C-C, where the Tidal Volume of one patient was decreased by 30% whilst maintaining the other pati... by José A. Solís-Lemus (9272948)

Decreased survival of HL60 cells after fractionated irradiation. by Annette Geltmeier (779536)

Table_4_NOTCH1 mutation associates with impaired immune response and decreased relapse-free survival in patients with resected T1-2N0 laryngeal cancer.docx by Xiao-yang Gong (13103400)

“…A total of 469 genomic alterations were detected in 211 distinct cancer-relevant genes, and the genes found to be mutated in more than five patients (>10%) included tumor protein p53 (TP53, 78.5%), FAT atypical cadherin 1 (FAT1, 26%), LDL receptor related protein 1B (LRP1B, 19%), cyclin dependent kinase inhibitor 2A (CDKN2A, 17%), tet methylcytosine dioxygenase 2 (TET2, 17%), notch receptor 1 (NOTCH1, 12%) and neuregulin 1 (NRG1, 12%). …”

Table_1_NOTCH1 mutation associates with impaired immune response and decreased relapse-free survival in patients with resected T1-2N0 laryngeal cancer.docx by Xiao-yang Gong (13103400)

“…A total of 469 genomic alterations were detected in 211 distinct cancer-relevant genes, and the genes found to be mutated in more than five patients (>10%) included tumor protein p53 (TP53, 78.5%), FAT atypical cadherin 1 (FAT1, 26%), LDL receptor related protein 1B (LRP1B, 19%), cyclin dependent kinase inhibitor 2A (CDKN2A, 17%), tet methylcytosine dioxygenase 2 (TET2, 17%), notch receptor 1 (NOTCH1, 12%) and neuregulin 1 (NRG1, 12%). …”

Image_1_NOTCH1 mutation associates with impaired immune response and decreased relapse-free survival in patients with resected T1-2N0 laryngeal cancer.tif by Xiao-yang Gong (13103400)

“…A total of 469 genomic alterations were detected in 211 distinct cancer-relevant genes, and the genes found to be mutated in more than five patients (>10%) included tumor protein p53 (TP53, 78.5%), FAT atypical cadherin 1 (FAT1, 26%), LDL receptor related protein 1B (LRP1B, 19%), cyclin dependent kinase inhibitor 2A (CDKN2A, 17%), tet methylcytosine dioxygenase 2 (TET2, 17%), notch receptor 1 (NOTCH1, 12%) and neuregulin 1 (NRG1, 12%). …”

Table_3_NOTCH1 mutation associates with impaired immune response and decreased relapse-free survival in patients with resected T1-2N0 laryngeal cancer.docx by Xiao-yang Gong (13103400)

“…A total of 469 genomic alterations were detected in 211 distinct cancer-relevant genes, and the genes found to be mutated in more than five patients (>10%) included tumor protein p53 (TP53, 78.5%), FAT atypical cadherin 1 (FAT1, 26%), LDL receptor related protein 1B (LRP1B, 19%), cyclin dependent kinase inhibitor 2A (CDKN2A, 17%), tet methylcytosine dioxygenase 2 (TET2, 17%), notch receptor 1 (NOTCH1, 12%) and neuregulin 1 (NRG1, 12%). …”